Baker Bros. Advisors LP Isoray, Inc. Transaction History

Baker Bros. Advisors LP

  • $7.52 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
N/A
-7,489,916 Reduced 98.04%
149,787 $103,000
Q3 2023

Nov 14, 2023
BUY
N/A
5,320,417 Added 229.4%
7,639,703 $5.27 Million
Q2 2023

Aug 14, 2023
BUY
$0.0 - $0.69 $0 - $1.6 Million
2,319,286 New
2,319,286 $1.6 Million

Others Institutions Holding ISR

# of Institutions
4
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About Isoray, Inc.

ISR Quotes by TradingView
  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email